Tag: IPO

Categories
Corporate

Anthropic plans $60 billion IPO amid AI boom

Anthropic, the artificial intelligence firm behind the Claude chatbot, is preparing for a potential initial public offering (IPO) that could value the company at over $60 billion. The listing is reportedly being targeted for October 2026, though plans are still in the early stages.

Founded in 2021 by former researchers from OpenAI, Anthropic has quickly positioned itself as a major player in the rapidly expanding AI industry. Its flagship product, Claude, is widely used for a range of applications, from enterprise solutions to everyday digital tasks, helping the company gain strong traction in a competitive market.

The proposed IPO reflects growing investor interest in artificial intelligence companies, as demand for advanced AI systems continues to surge globally. Industry experts believe that Anthropic’s listing could become one of the most significant tech IPOs in recent years, highlighting the increasing value placed on AI-driven innovation.

Reports suggest the company has begun preliminary discussions with leading investment banks to manage the offering. While details are yet to be finalised, the funds raised through the IPO are expected to support large-scale investments in computing infrastructure, including data centres and high-performance hardware. These investments are essential for training and deploying more advanced AI models.

Anthropic is often seen as a key competitor to OpenAI, with both companies racing to develop more powerful and efficient AI technologies. The rivalry underscores the broader competition within the tech industry, where companies are investing heavily to gain an edge in generative AI.

Despite the strong interest, the IPO timeline and valuation remain subject to change depending on market conditions and regulatory approvals. However, the move signals confidence in the long-term growth of the AI sector.

Also Read: India approves ₹2.38 lakh cr defence boost

Categories
Corporate

Sai Parenterals IPO subscribed 4% on day 1

The initial public offering (IPO) of Sai Parenterals began on a subdued note, with the issue receiving only about 4% subscription on the first day of bidding.

Data shows that the IPO attracted limited bids compared to the total shares on offer, reflecting cautious investor sentiment. The weak response comes at a time when market participants are increasingly selective in the primary market.

The ₹409 crore issue, which opened on March 24 and will close on March 27, includes both a fresh issue of shares and an offer for sale. The company has fixed a price band of ₹372 to ₹392 per share.

Market signals also indicate a lack of strong enthusiasm. The grey market premium (GMP), often seen as an indicator of listing gains, remains flat, suggesting expectations of a modest or neutral debut on the stock exchanges.

Analysts attribute the slow start to a combination of factors, including valuation concerns and overall market uncertainty. Investors are closely evaluating company fundamentals and growth potential before committing funds, particularly in mid-sized IPOs.

The pharmaceutical sector, while generally stable, has seen mixed interest in recent public issues, further contributing to the cautious approach among investors.

The company plans to use the funds raised for expansion, working capital needs and general corporate purposes. However, experts advise potential investors to review the firm’s financials and long-term outlook before making decisions.

Despite the muted opening, subscription levels could improve in the coming days, as institutional investors and retail participants often step in closer to the closing date.
Also Read: Oil prices drop on Iran negotiation talks

Categories
Corporate

Gaudium IVF lists at 5% premium on IPO debut

Shares of Gaudium IVF and Women Health made a steady debut on the stock exchanges, listing at ₹83, which is about 5% higher than the issue price of ₹79 per share. The modest premium came as a positive signal for investors, particularly given cautious sentiment in segments of the broader market.

The company’s initial public offering (IPO), valued at approximately ₹165 crore, had drawn strong interest during the subscription window. Retail investors and high-net-worth individuals led the demand, resulting in the issue being subscribed multiple times over. The listing performance exceeded muted expectations in the grey market, where informal indications had suggested a flatter start.

Gaudium IVF operates in the assisted reproductive technology space, offering fertility treatments including in-vitro fertilisation (IVF). The company follows a hub-and-spoke operating model, with main centres supported by satellite clinics to widen patient reach. It currently runs centres across key urban markets and plans to deepen its footprint.

According to its stated plans, proceeds from the IPO will primarily be used to fund expansion, including the launch of new IVF centres in different parts of the country. A portion of the funds will also go toward debt reduction and general corporate purposes, strengthening the balance sheet as it scales operations.

The fertility services market in India has been expanding, driven by rising awareness, lifestyle changes, and improving access to specialised healthcare. Industry analysts believe organised players with established brands and clinical track records are well positioned to benefit from this structural growth trend.

Also Read: US halts use of Anthropic AI

Categories
Leaders

Tablesh Pandey to lead NSE IPO committee plan

The National Stock Exchange of India (NSE) has taken a major step toward going public, as its board approved plans for an initial public offering (IPO) and formed a special IPO committee to oversee the process.

The IPO will be conducted via an offer-for-sale (OFS) route, in which existing shareholders sell their stake rather than the exchange issuing new shares. This approach helps determine NSE’s market valuation while retaining its overall ownership structure.

Former LIC Managing Director Tablesh Pandey has been appointed chairman of the IPO committee, bringing decades of experience in financial management, corporate governance, and regulatory compliance. Pandey is widely respected for his leadership at LIC, India’s largest insurance company, where he successfully steered growth, improved operational efficiency, and strengthened investor trust.

The IPO committee will include NSE’s Managing Director & CEO and public interest directors, ensuring strategic oversight of key steps such as finalizing the issue size, appointing merchant bankers, and preparing the Draft Red Herring Prospectus (DRHP).

A significant milestone for the exchange was the no-objection certificate (NOC) from SEBI, which clears a major regulatory hurdle for the listing. NSE aims to file the DRHP by end of March or early April, subject to audited financial statements and regulatory approvals.

The IPO is expected to unlock shareholder value and increase participation in India’s premier stock exchange. Analysts believe that with Pandey leading the committee, the process will benefit from strong governance, credibility, and smooth execution.

Pandey’s appointment is seen as a signal of the NSE’s commitment to transparency and regulatory compliance, given his proven track record in managing large public-sector financial institutions. Experts expect the IPO to be closely watched by both retail and institutional investors in India.

With the IPO committee now in place under Pandey’s guidance, NSE is on track to achieve a long-awaited listing, marking a major development in India’s capital markets.

Also Read: AI stethoscopes boost early health screening

Categories
1 Minute-Read

Turtlemint files ₹2,000 Cr IPO, eyeing April listing

Turtlemint Fintech Solutions, an insurtech platform founded in 2015, has filed an updated draft prospectus with SEBI for a proposed ₹2,000 crore IPO, targeting a listing by April.

The public offering will include both new shares and an offer-for-sale by existing investors. The company plans to use the proceeds to strengthen technology, expand infrastructure, and support business growth.

Early investors, including Nexus Venture Partners and Peak XV Partners, are expected to sell part of their holdings in the listing.

Categories
Corporate

Shadowfax IPO allotment done, 2.7x subscribed

Shadowfax Technologies Ltd has completed the allotment for its IPO, which attracted strong investor interest. The company’s public offering, valued at ₹1,907 crore, saw an overall subscription of 2.7 times, driven mainly by Qualified Institutional Buyers (QIBs), alongside notable retail participation. The IPO was open for bidding from January 20 to 22, 2026, and allotment was finalised on January 23.

Investors can check their allotment status through the registrar KFin Technologies or via the BSE and NSE websites. Those who did not receive an allocation will have their applications refunded in the coming days.

Shadowfax shares are scheduled to list on the Bombay Stock Exchange and National Stock Exchange on January 28, 2026. Grey market trends—a popular, though unofficial, indicator—suggest that shares could debut at or slightly below the issue price, reflecting cautious sentiment among investors.

The IPO price band was set at ₹118–₹124 per share, with retail investors required to buy a minimum lot of around ₹14,000. The company intends to use the funds to expand its logistics network, strengthen technology infrastructure, and support growth initiatives in its delivery business.

With the allotment completed and refunds underway for non-allocated applications, attention now turns to January 28, when trading begins. The subscription pattern highlighted strong institutional demand, with QIBs oversubscribing their portion, while the retail segment also showed solid participation.

Analysts note that the initial listing performance will be closely watched, as it will indicate investor confidence in Shadowfax’s expansion plans and operational model.

Also Read: Rupee slides to ₹92, raising costs for imports

Categories
1 Minute-Read

Shadowfax launches ₹1,907 cr IPO, mixed market response on Day 1

Shadowfax Technologies launched its ₹1,907 crore IPO on January 20, priced between ₹118–₹124 per share. The issue combines new shares and an offer for sale by existing investors and will remain open until January 22.

Early data shows moderate overall subscription, with retail investors showing the strongest interest. The grey market indicates potential listing gains of 5–6%, though analysts warn valuations are on the higher side compared to industry peers.

Investors are advised to consider the company’s growth prospects before applying.

Categories
Corporate

BCCL ₹1,071 cr IPO sees strong demand

Bharat Coking Coal Ltd (BCCL), a subsidiary of Coal India Ltd, launched its initial public offering (IPO) on January 9, 2026, priced at ₹21–23 per share. The IPO, entirely structured as an offer-for-sale (OFS), aims to raise approximately ₹1,071 crore from investors. It marks one of the first major public offers of 2026 and has attracted considerable attention from retail, institutional, and non-institutional investors.

The subscription process is open until January 13, with allotment expected on January 14. Shares are likely to debut on the BSE and NSE on January 16. Early indications suggest strong demand across all investor categories, reflecting confidence in BCCL’s market position and backing from its parent company, Coal India.

The grey market premium (GMP) for the BCCL IPO is signaling potential listing gains of 40–50%, a robust figure that has further piqued investor interest. Analysts note that BCCL, being a government-backed coal producer with a strong operational track record, presents a relatively low-risk investment option with good growth prospects.

BCCL operates in the coking coal segment, supplying a critical raw material for steel production. The company’s parentage under Coal India Ltd provides additional credibility, attracting both retail and institutional investors looking for stable government-linked opportunities. Market experts believe that the strong grey market activity combined with oversubscription trends indicates a healthy appetite for government-linked IPOs in the current market scenario.

The public offer is also expected to enhance BCCL’s visibility among investors and strengthen its financial profile. Analysts recommend subscribing to the IPO, citing both its strategic importance in India’s coal sector and the potential upside at listing.

 The BCCL IPO is being seen not just as a financial opportunity but also as a barometer of investor sentiment toward government-backed enterprises in the early part of 2026.

Also Read: Zoho founder Vembu faces $1.7bn bond in divorce case

Categories
Corporate

Bharat Coking Coal IPO price set at ₹21–₹23

Bharat Coking Coal Limited (BCCL), a subsidiary of Coal India Limited, has fixed the price band for its initial public offering (IPO) at ₹21 to ₹23 per share. The company plans to raise about ₹1,071 crore through this issue, which will be entirely an offer-for-sale (OFS). This means Coal India will sell part of its stake, while BCCL itself will not receive any fresh funds from the IPO.

The IPO will open for public subscription on January 9 and close on January 13. Anchor investors will be able to bid a day earlier, on January 8. Shares are expected to be listed on the BSE and NSE on January 16, subject to final approvals.

The issue consists of up to 46.57 crore equity shares with a face value of ₹10 each. Retail investors can apply for a minimum of one lot of 600 shares. At the lower end of the price band, the minimum investment works out to about ₹12,600, while at the upper end it is around ₹13,800. Eligible employees will get a discount of ₹1 per share.

As per market rules, up to 50% of the issue is reserved for qualified institutional buyers (QIBs), 35% for retail investors, and 15% for non-institutional investors such as high-net-worth individuals. Separate reservations have also been made for eligible employees and existing Coal India shareholders.

Market interest in the IPO appears strong. In the grey market, BCCL shares are reportedly trading at a premium of around ₹16 per share, suggesting expectations of a healthy listing gain. However, investors are advised to note that grey market premiums are unofficial and can change quickly.

Bharat Coking Coal is one of India’s key producers of coking coal, which is mainly used in steel making. The company operates largely in Jharkhand and West Bengal, including the Jharia coalfields. Its listing is part of the government’s broader plan to unlock value from public sector subsidiaries and improve transparency through market participation.

Also Read: Air India seeks new CEO as leadership changes loom

Categories
Corporate

SEBI clears 8 IPOs, Indira IVF among them

The Securities and Exchange Board of India (SEBI) has approved initial public offering (IPO) plans of eight companies, signalling steady activity in the primary market. The companies that received the regulator’s clearance include Indira IVF, Rays of Belief, RKCPL Ltd, Chartered Speed, Glass Wall Systems (India), Shriram Food Industry, Tempsens Instruments (India), and Jerai Fitness.

SEBI’s approval, referred to as regulatory “observations”, allows these companies to move ahead with their IPO process. They can now update their offer documents, finalise issue details, and plan market launches, depending on investor demand and market conditions.

Among the approved firms, Indira IVF stands out as a well-known fertility care provider with clinics across several Indian cities. The company had earlier withdrawn its IPO papers and later refiled them using the confidential route, which keeps draft documents private until SEBI grants its observations. Rays of Belief, which works in child development and therapy services, also used the confidential filing route and has now received approval.

The remaining companies filed their IPO applications through the regular process. RKCPL Ltd operates in the infrastructure and civil construction space, while Chartered Speed provides passenger transport and mobility services. Glass Wall Systems (India) is engaged in façade and building solutions, supplying products for commercial and residential projects.

Shriram Food Industry is involved in food processing and exports, and Tempsens Instruments (India) manufactures thermal engineering products and specialised cables used in industrial applications. Jerai Fitness, another company on the list, is known for making gym and fitness equipment for both commercial and home use.

The approvals were issued between late December and early January. Once SEBI observations are received, companies usually have a limited period to launch their IPOs, subject to market conditions.

Market participants see these approvals as a positive sign for India’s IPO pipeline. The presence of companies from diverse sectors such as healthcare, infrastructure, manufacturing, fitness, and food processing reflects broad interest in raising funds from public investors. Investors are now expected to closely watch the final offer details and timelines of these upcoming IPOs.

Also Read: Adani Enterprises opens Rs 1,000 cr NCD issue